| ID | Sequence | Length | GC content |
|---|---|---|---|
| CCAACGCGCAGGCGCCGCUGCUAUGCUGAGUGCCGCGUCUCGCGUAGUC… | 2514 nt | 0.5501 | |
| AACGCGCAGGCGCCGCUGCUAUGCUGAGUGCCGCGUCUCGCGUAGUCUC… | 1360 nt | 0.6103 |
The protein encoded by this gene belongs to the aldo/keto reductase (AKR) superfamily and AKR7 family, which are involved in the detoxification of aldehydes and ketones. The AKR7 family consists of 3 genes that are present in a cluster on the p arm of chromosome 1. This protein, thought to be localized in the golgi, catalyzes the NADPH-dependent reduction of succinic semialdehyde to the endogenous neuromodulator, gamma-hydroxybutyrate. It may also function as a detoxication enzyme in the reduction of aflatoxin B1 and 2-carboxybenzaldehyde. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
A pilot study in humans investigated the AKR7A2 as a potential biomarker for gamma-hydroxybutyric acid (GHB) intake via qPCR analysis of blood samples from three patients therapeutically taking GHB and 49 control donors [Mehling et al. DOI:10.1007/S00414-017-1609-3].